REJUVENX OF BRADENTON, LLC
BRADENTON, FLORIDA

REJUVENX OF BRADENTON, LLC is an Active company incorporated on January 26, 2021 with the registered number L21000023963. This Florida Limited Liability company is located at 3021 MANATEE AVE WEST, SUITE A AND B, BRADENTON, FL, 34205, US and has been running for five years. There are currently three active principals.

KEY FACTS ABOUT REJUVENX OF BRADENTON, LLC

  1. US Businesses
  2. Companies in Florida
  3. Manatee County Companies
Company name
REJUVENX OF BRADENTON, LLC
Status
Active
Filed Number
L21000023963
FEI Number
861733518
Date of Incorporation
January 26, 2021
Age - 5 years
Home State
FL
Company Type
Florida Limited Liability

REJUVENX OF BRADENTON, LLC NEAR ME

Principal Address
3021 MANATEE AVE WEST, SUITE A AND B,
BRADENTON,
FL,
34205,
US
Mailing Address
1425 E Venice Ave,
Suite 104, #279,
Venice,
FL,
34292,
US

See Also

REJUVENX MARKETING AND STAFFING, LLC REJUVENX OF BOYNTON BEACH, LLC REJUVENX OF FT. MYERS, LLC. REJUVENX OF NAPLES, LLC REJUVENX OF SARASOTA, LLC

Officers and Directors

The REJUVENX OF BRADENTON, LLC managed by the three persons and three company from Venice on following positions: Authorized Representative, Manager

Jeremiah Joseph

Position
Authorized Representative Active
From
Venice, FL
Jeremiah Joseph Related Companies
  1. REJUVENX OF ST. PETE, LLC
  2. PRECISION PAIN, LLC
  3. REJUVENX OF NAPLES, LLC
  4. REJUVENX OF BOYNTON BEACH, LLC
  5. REJUVENX OF SARASOTA, LLC
  6. PRECISION PAIN OF SARASOTA, LLC

Tim Decanio

Position
Authorized Representative Active
From
Venice, FL
Tim Decanio Related Companies
  1. SOUTH FLORIDA PHYSICAL MEDICINE PLLC
  2. FLORIDA IMAGING, LLC
  3. REJUVENX OF WEST PALM BEACH, LLC
  4. REJUVENX OF ST. PETE, LLC
  5. REJUVENX OF VENICE, LLC
  6. PRECISION PAIN, LLC

REJUVENX HOLDINGS

Position
Manager Active
Address
1425 E Venice Ave, Venice, FL, 34292
REJUVENX HOLDINGS Related Companies



Registered Agent is Timothy Decanio

From
Venice, 34292

Events

November 14, 2022
LC AMENDMENT
June 14, 2021
LC AMENDMENT

Annual Reports

2025
March 13, 2025
2024
April 29, 2024